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Abstract 
Purpose 
The purpose of this project is to evaluate adherence to Physician Quality Reporting 
System (PQRS) Measures #331 (delaying antibiotic treatment until at least seven days of 
symptoms) and #332 (prescribing amoxicillin or amoxicillin/clavulanate) on adult sinusitis 
treatment. Data was collected from patient encounters at the University of Kentucky College of 
Nursing Community Health Center (UKCONCHC) in Wilmore, Kentucky. To adhere to these 
quality measures would foster antibiotic stewardship. Further statistical analysis was completed 
to determine if gender or age bias was present in prescribing practices. 
Methods  
A retrospective chart audit was conducted to determine adherence to the quality 
measures. Records were also reviewed to determine if recommended antibiotics by the 
American Academy of Otolaryngology Head and Neck Surgery (AAOHNS) (Rosenfeld et al., 
2015) were prescribed for patients with penicillin allergies. A total of 30 patient encounters 
met inclusion criteria. Information regarding patient age, gender, allergies, days of symptoms 
experienced, and antibiotic prescribed (if any) were collected.  
Results  
The adherence rate to Objective 1 (delaying antibiotic treatment until at least seven 
days of symptoms) was 60%. The adherence rate to Objective 2 (prescribing amoxicillin or 
amoxicillin/clavulanate) was 89.2%. The adherence rate to Objective 2, when adherence to 
Objective 1 was a prerequisite, was 53.5%. The adherence rate to Objective 3 (prescribing 
doxycycline or a fluroquinolone when a penicillin allergy is present) was 50%. No gender or 
age bias was observed in regard to antibiotic prescribing practices.  
Conclusion 
 In conclusion, the adherence rates demonstrated adequate adherence to PQRS measures 
#331 and #332 and the AAOHNS guideline. Attention should be focused on improving 
adherence to PQRS measure #331 (delaying antibiotic therapy until at least seven days of 
symptoms). 
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An Evaluation of Provider Adherence to Adult Acute Quality Measures and Guideline 
Introduction 
Acute sinusitis is an illness caused by the inflammation of the paranasal sinuses and 
nasal cavity, which can last up to four weeks. Sinusitis can be the result of a viral or bacterial 
infection (Rosenfeld et al., 2015). In the United States, sinusitis is given as the primary 
diagnosis over 30 million times annually by health care providers (Blackwell, Lucas, & 
Clarke, 2014). In a large, retrospective analysis Benninger, Holy and Trask (2016) observed 
that antibiotic prescriptions for acute rhinosinusitis were written over 80% of the time. 
According to the Centers for Disease Control and Prevention (CDC) (2015), 90-98% of 
rhinosinusitis occurrences are due to a viral organism, not a bacteria. With such frequent use of 
antibiotic therapy for acute sinusitis, resistance has become both a reality and a concern. In 
fact, the CDC (2013) has deemed antibiotic utilization as the most significant influence of 
antibiotic resistance. Antibiotics are not an effective treatment for viral infection; therefore, the 
likelihood is high that many antibiotic prescriptions are not reducing severity or length of 
illness course for acute rhinosinusitis. Antibiotic stewardship, which is a concept that 
emphasizes the responsible use of antibiotic therapy, can help to slow the process of antibiotic 
resistance (CDC, 2013).  
The most common bacteria associated with causing sinusitis are Strep pneumoniae, 
Haemophilus influenza, and Moraxella catarrhalis (Sinus and Allergy Health Partnership, 
2004). These bacteria are susceptible to amoxicillin or amoxicillin/clavulanate, which are 
considered first-line therapies (Rosenfeld et al., 2015). Depending on local resistance patterns, 
amoxicillin/clavulanate may be necessary to treat sinusitis if causative bacteria produce beta-
lactamase. Amoxicillin is recommended as the first line therapy for several reasons including: 
low side effect profile, narrow spectrum coverage, inexpensiveness, and effectiveness 
(Ahovuo-Saoranta et al., 2014; de Bock et al., 1997; Lau et al., 1999; Sinus and Allergy 
Health Partnership, 2004; Snow et al., 2001). 
The Centers for Medicare & Medicaid Services (2015) have published quality measures 
(Physician Quality Reporting System-PQRS) regarding appropriate antibiotic use in the 
treatment of sinusitis in adults. The measures, #331 and #332, advise the appropriate utilization 
of antibiotics seven days after diagnosis or 10 days after onset of symptoms (#331) and 
recommend the use of amoxicillin or amoxicillin/clavulanate as initial treatment (#332). These 
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quality measures are based on evidence-based clinical practice guidelines published by the 
American Academy of Otolaryngology-Head and Neck Surgery (AAOHNS) in 2015 
(American Medical Association, 2015; Rosenfeld et al., 2015). By adhering to these quality 
measures, antibiotic stewardship is encouraged and the potential to slow the process of 
antibiotic resistance exists (Cantas et al., 2013; Lee, Cho, Jeong, & Lee, 2013; Centers for 
Disease Control and Prevention, 2013). 
The current AAOHNS guideline is an update of the 2007 version of the sinusitis 
treatment recommendations (Rosenfeld et al., 2015). These guidelines provide direction for 
the management of sinusitis beyond what is evaluated by PQRS measures #331 and #332. The 
information within the AAOHNS guideline is particularly helpful when dealing with patients 
who cannot receive the recommended treatment and necessitate an alternative. For example, 
patients with a penicillin allergy that have been diagnosed with bacterial sinusitis cannot be 
prescribed amoxicillin or amoxicillin/clavulanate due to their allergy. The AAOHNS 
(Rosenfeld et al., 2015) recommends the use of doxycycline or a fluoroquinolone to treat 
sinusitis in patients who are allergic to penicillin.  
Purpose 
The purpose of this project was to evaluate provider adherence to PQRS Measures #331 
and #332 on adult sinusitis treatment.  
Objectives 
The overall objective of the project was to evaluate antibiotic use for adults diagnosed 
with acute sinusitis at the University of Kentucky College of Nursing Community Health 
Center (UKCONCHC) from March 29, 2016- September 20, 2016. The specific objectives of 
the project were to: 
Objective 1: Evaluate the adherence of nurse practitioners to PQRS Measure #331 
(appropriate use of antibiotics). 
Objective 2: Evaluate the adherence of nurse practitioners to PQRS measure #332 (use of 
amoxicillin or amoxicillin/clavulanate). 
Objective 3: Evaluate the adherence of UKCONCHC nurse practitioners to the AAOHNS 
guideline recommendation to prescribe doxycycline or a fluoroquinolone for patients diagnosed 
with acute sinusitis who are allergic to penicillin.  
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Methods 
Design 
A univariate descriptive study design was used to observe the level of adherence to PQRS 
measures #331 and #332 and the AAOHNS guideline recommendation for patients with 
penicillin allergies. A retrospective chart audit was conducted. 
Study Permission 
 Permission to conduct this study was received from Dr. Sharon Lock, Clinic Director of 
the UKCONCHC. In addition, prior to initiation of this study permission was received from the 
Institutional Review Board (IRB) via expedited review at the University of Kentucky in 
Lexington, Kentucky.   
Study Population 
The sample for this study was based on adult patient encounters at the UKCONCHC 
from March 29, 2016 - September 20, 2016. Inclusion criteria for the chart audit was 1) 
patient 18 years old or older at time of patient encounter, and 2) an ICD-10 (J01-J01.91) 
diagnosis of acute sinusitis. Patients with a documented allergy to penicillin and a diagnosis 
of acute sinusitis were included to evaluate appropriate antibiotic use. Exclusion criteria were 
patients less than 18 years old. A total of 30 patient encounters met inclusion criteria.  
Setting 
 The UKCONCHC is licensed as a limited services clinic and has been open since 
September 14, 2015. Several University of Kentucky College of Nursing faculty members are 
the health care providers for the clinic.  
Data Extraction Procedures 
The University of Kentucky Center for Clinical and Translational Science (CCTS) 
assembled a list of medical record numbers of patients who met inclusion criteria.  
 The principal investigator reviewed the medical records and extracted data concerning 
patient age, gender, allergies to antibiotics, ICD-10 code, onset of symptoms (number of days), 
and antibiotic prescribed (if any).  
Data Analysis 
 To analyze the data for Objective 1, the following procedure was followed. For each 
patient encounter that met inclusion criteria, a label of ‘yes’ or ‘no’ was applied in regard to 
whether or not the seven days of experienced symptoms was met. This coding provided the data 
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for Objective 1. For the purposes of this study, a ‘yes’ label was given if symptoms were 
documented to have been occurring for 7 days or more. Technically, PQRS measure #331 states 
that antibiotics should only be given seven days after diagnosis or 10 days after onset of 
symptoms (Center for Medicare & Medicaid Services, 2015). However, providers often prescribe 
antibiotics after 7-10 days of symptoms (American Academy of Family Physicians, 2017; Aring 
& Chan, 2016; Patel & Hwang, 2017). The manner of this portion of the data analysis is 
reflective of this common practice. A frequency was calculated to determine provider adherence 
to PQRS measure #331.  
 For Objective 2, there were two interpretations of the data. Patients who were 
documented to have a penicillin allergy were excluded from data computations for Objective 2. 
The first interpretation looked at whether or not amoxicillin or amoxicillin/clavulanate was 
prescribed when sinusitis was diagnosed, irrespective of duration of symptoms. If amoxicillin or 
amoxicillin/clavulanate was prescribed, the encounter was labeled as ‘yes.’ If amoxicillin or 
amoxicillin/clavulanate was not prescribed, the patient encounter was labeled as ‘no.’ A 
frequency was calculated to determine provider adherence to this interpretation of PQRS 
measure #332.  
 For the second interpretation of the data for Objective 2, adherence to Objective 1 
(minimum of 7 days of experienced symptoms prior to antibiotic prescription) was taken into 
consideration. Patients with a documented penicillin allergy were excluded from this data 
computation. Patient encounters were labeled as either ‘yes’ or ‘no.’ For this interpretation, 
adherence to Objective 1 (PQRS measure #331), was a prerequisite for adherence to Objective 2 
(PQRS measure #332). If a patient encounter was adherent to Objective 1 and Objective 2, the 
encounter was labeled as a ‘yes.’ If a patient encounter was adherent to Objective 1 and was not 
adherent to Objective 2, the encounter was labeled as ‘no.’ If a patient encounter was not 
adherent to Objective 1, but had been prescribed amoxicillin or amoxicillin/clavulanate, the 
encounter was labeled as ‘no.’ In these instances, the antibiotic prescription could be considered 
incorrect due to the minimum number of days of symptoms not being met. A frequency was 
calculated to determine provider adherence to PQRS measure #332, when considering adherence 
to PQRS measure #331 as a prerequisite.  
 For Objective 3, only patient encounters with a documented allergy to penicillin were 
included for this portion of data analysis. Patient encounters were labeled as a ‘yes’ if symptoms 
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had been present for a minimum of 7 days and if doxycycline or a fluoroquinolone was 
prescribed. Patient encounters were labeled as ‘no’ if either symptoms had been present for less 
than 7 days or if an antibiotic other than doxycycline or a fluoroquinolone was prescribed. This 
is in alignment with a recommendation from the AAOHNS (Rosenfeld et al., 2015). A frequency 
was calculated to determine provider adherence to the AAOHNS measure.  
Results 
Objective 1 
 Objective 1 sought to examine adherence to PQRS measure #331, which advises sinusitis 
symptoms to be present for a minimum of seven days prior to antibiotics prescription. A total of 
30 patient encounters met inclusion criteria. Each of these patient encounters resulted in an 
antibiotic prescription. The data revealed that 18 of these 30 patient encounters had experienced 
a minimum of seven days of sinusitis symptoms before an antibiotic was prescribed. Therefore, 
an adherence rate of 60% (18/30) was demonstrated by providers at the UKCONCHC to PQRS 
measure #331.  
 
Objective 2  
 Objective 2 assessed adherence to PQRS measure #332, which advises the prescription of 
amoxicillin or amoxicillin/clavulanate for adult patients diagnosed with sinusitis. Therefore, 
patients with a documented allergy to penicillin were excluded from this portion of data analysis. 
For the chart audit, 28 patient encounters were examined for Objective 2. Each of these patient 
encounters included an antibiotic prescription. Of these 28 patient encounters, 25 were 
prescribed amoxicillin or amoxicillin/clavulanate. Thus, providers at the UKCONCHC were 
89.3% adherent to PQRS measure #332. This frequency does not consider whether or not the 
sinusitis symptoms had been experienced for a minimum of seven days. 
 It is important to realize some of the patient encounters that were not adherent to PQRS 
measure #331 were labeled as adherent to PQRS measure #332. After taking into account both 
quality measures the percentage of adherence is lowered. In other words, to be labeled as 
adherent to PQRS measure #332, the patient encounter must be labeled as adherent to PQRS 
measure #331, as a prerequisite. To look at the data in this manner reflects true antibiotic 
appropriateness and demonstrates antibiotic stewardship. The combination of these two quality 
measures work together to practice antibiotic stewardship.  The number of patient encounters 
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that were adherent to PQRS measure #331 and #332 were 15 out of the total 28 patient 
encounters. Thus, after taking into consideration adherence to PQRS measure #331, providers at 
the UKCONCHC demonstrated an adherence rate of 53.5% (15/28) to PQRS measure #332.  
Objective 3 
 Objective 3 sought to observe adherence to the AAOHNS guideline recommendation 
(Rosenfeld et al., 2015), which advises the prescription of a fluroquinolone or doxycycline for 
the treatment of sinusitis among adults in the presence of a penicillin allergy. Of the 30 patient 
encounters included in the study, only 2 patient encounters were documented to have a penicillin 
allergy. Of those 2 patient encounters, 1 chart was adherent to the AAOHNS guideline. 
Therefore, an adherence rate of 50% (1/2) was observed to the AAOHNS guideline by providers 
at the UKCONCHC clinic.  
 Data were also analyzed to determine if gender and age influenced provider adherence. 
For the analysis concerning gender and provider adherence, a Chi-Square analysis was computed 
using the SPSS program, version 23, by IBM.  A total of 28 patient encounters were included in 
this analysis. Males accounted for 8 patient encounters. Females accounted for 20 patient 
encounters. The data for Objective 2, which viewed adherence to PQRS measure #331 as a 
prerequisite for adherence to Objective 2, was utilized for this computation. There was no 
significant difference of provider adherence rates between male and female patients (p >0.05).   
To explore if patient age influenced provider adherence rates, an Independent Samples T-
Test was run in the SPSS program, version 23, by IBM. A total of 28 patient encounters were 
included for this analysis. The data included for this analysis considered adherence to PQRS 
measure #331 as a prerequisite to adherence for adherence to Objective 2. There was no 
significant difference (p >0.05) between patient age and provider adherence rate. 
Discussion 
The results show that nurse practitioners at the UKCONCHC are prescribing antibiotics 
for sinusitis after at least seven days of symptoms (PQRS measure #331) 60% of the time. When 
antibiotics are prescribed for sinusitis among patients without a penicillin allergy, 89.3% receive 
a prescription for amoxicillin or amoxicillin/clavulanate (PQRS measure #332). When 
accounting for the presence of at least 7 days of sinusitis symptoms and amoxicillin or 
amoxicillin/clavulanate being prescribed, 53.5% of patient encounters met both quality 
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measures. For patients with a penicillin allergy and diagnosed with sinusitis, a fluroquinolone or 
doxycycline was prescribed (AAOHNS guideline) in 50% of patient encounters.  
While these rates are commendable, there is room for improved adherence to these 
quality measures and guideline. At first thought, one might believe that this adherence rate is 
strictly due to the knowledge and practice of the providers. However, it is important to appreciate 
that some patients come to medical appointments with preconceived expectations. Some of these 
patients may be of the belief that their illness necessitates an antibiotic when, in fact, current 
guidelines state otherwise (Rosenfeld et al., 2015). Despite patient education, some patients are 
persistent enough to persuade the provider to prescribe an unnecessary antibiotic. The PQRS 
measures included in this study encourage more cautious use of antibiotics. This is in contrast to 
medical practice within the last 15 years, during which over 80% of visits for sinusitis included 
an antibiotic prescription (Benninger, Holy & Trask, 2016; Smith et al., 2013). Over time, it is 
hoped that general knowledge of current guidelines will be disseminated among the public so 
that patients will be more accepting of less aggressive treatment plans. As this occurs, adherence 
to the quality measures of PQRS will be improved.  
  Presently, there exists a void in the literature regarding adherence rates of these quality 
measures and guideline. This is likely due to their relatively recent publication within the past 
two years. Therefore, at this time, it is not possible to compare the adherence rates at the 
UKCONCHC to other clinics or national trends because the data has not been analyzed or made 
public. Though not necessarily reflective of current practice, the most recent data has indicated 
that antibiotics are prescribed over 80% of the time when sinusitis is diagnosed (Benninger, Holy 
& Trask, 2016; Smith et al., 2013). This data does not consider the duration of symptoms; 
however, according to the CDC (2015), 90-98% of rhinosinusitis is due to a viral organism, not a 
bacteria. When considering this, only 10% of sinusitis cases, at most, warrant an antibiotic 
prescription. Thus, the most recent data demonstrates the over prescription of antibiotics for this 
condition. It is clear that more cautious use of antibiotics is needed. Historically, adult sinusitis 
clinical practice guidelines have impacted the management of sinusitis (Bhattacharyya & 
Kepnes, 2013). The improvements to practice have not occurred at an exceedingly high degree as 
the over prescription of antibiotics for sinusitis has continued (Benninger, Holy & Trask, 2016; 
Smith et al., 2013).  
Adherence to these quality measures and guideline not only affect the patients of the 
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UKCONCHC, but also contribute to staving off the bigger issue of antibiotic resistance. 
Antibiotic resistance has increased in recent years, along with new resistance patterns 
emerging (CDC, 2013). The overuse of antibiotics has had a direct impact on antibiotic 
resistance by advancing the process (Cantas et al., 2013; Lee, Cho, Jeong, & Lee, 2013). As 
antibiotic resistance continues to develop, current first-line treatments have become useless in 
some instances (CDC, 2013). It is important to note the ramifications of antibiotic resistance 
reach beyond simply prescribing a different antibiotic. Annually, at least two million people 
become infected with antimicrobial resistant bacteria and an estimated 23,000 people die from 
these infections in the United States (CDC, 2013). Infection with antibiotic resistant bacteria 
has been correlated with increased morbidity following initial infection (Huang et al., 2011). 
Cosgrove (2006) and Huang et al. (2011) demonstrated that antibiotic resistant bacteria led to 
increased mortality among those who had acquired a resistant infection. 
The economic burden of antimicrobial resistance is also profound. Antimicrobial 
resistance has been associated with increases in medical costs and duration of hospital stay 
(Cosgrove, 2006; Roberts et al., 2009). Further, antibiotic stewardship has been shown to save 
money in the healthcare setting (Beardsley et al., 2012; Standiford et al., 2012). 
In an effort to stave off antibiotic resistance, the CDC has created the Antibiotic 
Resistance (AR) Solutions Initiative (CDC, 2017a). The conception of this initiative speaks to 
the recognized threat antibiotic resistance has on the health of current and future generations. 
Two pieces of this initiative include the implementation of antibiotic stewardship programs in 
doctors’ offices and continuing education program regarding current guidelines in hopes of 
eliminating inappropriate antibiotic prescribing (CDC, 2017b). Through the AR Solutions 
Initiative, over $1.1 million dollars were spent on antibiotic resistance activities during fiscal 
year 2016 in Kentucky. Over $500,000 dollars were invested in efforts to improve antibiotic 
stewardship by educating medical providers and the general public (CDC, 2016a).  
Limitations 
 For this study, several limitations are identified. The first limitation of this study is the 
small sample size. As with any research endeavor, the larger the sample size, the more reliable 
results become. The small sample size can be attributed to several factors. For one, the dates set 
by the inclusion criteria did not include the Fall or Winter months. It would be expected to 
experience a larger volume of patient encounters with a chief complaint of sinusitis symptoms 
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during these months, which in turn would have provided a larger study sample. A wider date 
range for inclusion criteria was not selected for this study due to a change in electronic medical 
record platform. Prior to March 29, 2016, the UKCONCHC used McKesson Practice Choice as 
the electronic health record (EHR). The clinic transitioned to UKHC Ambulatory Electronic 
Health Record (AEHR) on March 29, 2016. Paper copies of the McKesson records were 
available, but the records could not be searched electronically. Therefore, for this project, only 
records from the UKHC AEHR were reviewed. In addition, the UKCONCHC had been open less 
than one year during the inclusion criteria dates. Limited local knowledge of the clinic could also 
have contributed to the small sample size. Lastly, the clinic is located in a small town without a 
large amount of economic activity. It is located about 10 minutes from a larger town within the 
county that has several primary care offices.  
 A second limitation of the study is the opportunity for providers to use several ICD-10 
diagnosis codes for upper respiratory symptoms, many of which do not indicate sinusitis. The 
current AAOHNS guideline (Rosenfeld et al., 2015) defines acute bacterial rhinosinusitis as 
“symptoms of…rhinosinusitis persist without evidence of improvement for at least 10 days” (p. 
S6). This guideline definition encourages practitioners to not use ICD-10 diagnosis codes J01-
J01.91 for sinusitis until symptoms meet the minimum number of days of symptoms. There may 
be a tendency for medical practitioners to label patient encounters with other diagnosis codes, 
such as upper respiratory infection, when the minimum number of symptom days has not been 
met and the causative agent is suspected to be viral.  This tendency is evidenced by the study 
sample. Each patient encounter that met inclusion criteria included an antibiotic prescription. A 
higher rate of adherence to PQRS measure #331 may have been observed if patient encounters 
were diagnosed as sinusitis earlier in illness course or if other diagnosis codes, such as upper 
respiratory infection, were included in the inclusion criteria.  
Another limitation of this study is that data extraction procedures did not observe for the 
presence of delayed prescription writing. This concept allows for providers to write an antibiotic 
prescription that will not become active until after the minimum seven days of symptoms have 
been experienced. If delayed prescription writing had been taken into account, there may have 
been an increase in adherence rates, in particular to PQRS measure #331. 
 Another limitation of this study was the exclusion of the phenomenon known as double 
worsening from the data analysis (Rosenfeld et al., 2015). Double worsening is defined as the 
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worsening of acute rhinosinusitis symptoms after initial improvement within 10 days of 
symptom onset (Rosenfeld et al., 2015). The AAOHNS guideline states that antibiotics can be 
prescribed if double worsening has occurred (Rosenfeld et al., 2015). This phenomenon was not 
taken into consideration during data extraction procedures because PQRS measures #331 and 
#332 do not include double worsening to warrant antibiotic use. However, nurse practitioners at 
the UKCONCHC may have prescribed antibiotics within the 10 day window due to double 
worsening, which is appropriate antibiotic use according to the AAOHNS guideline (Rosenfeld 
et al., 2015). Double worsening could have been a piece of the exclusion criteria for this study to 
help control for the influence of the AAOHNS guideline in practice. This would not be done to 
insinuate that prescribing antibiotics in the presence of double worsening is incorrect. Rather, 
this would be done because the aim of this study was to observe adherence to PQRS measures 
#331 and #332. Currently, PQRS does not address double worsening in its’ quality measures. As 
previously stated, PQRS measures #331 and #332 were written to mirror the recommendations 
from the AAOHNS guideline (American Medical Association, 2015). However, as this limitation 
illustrates, they were not mirrored verbatim. 
 The aforementioned example of the PQRS measures and AAOHNS guideline containing 
different information leads the discussion to another limitation of this study. It is important to 
realize that PQRS is a quality improvement program, not a treatment guideline (Centers for 
Medicare & Medicaid Services, 2015). Nonetheless, there are other sinusitis treatment guidelines 
besides the AAOHNS guideline that have been published by reputable organizations, like the 
Infectious Disease Society of America (IDSA). The IDSA treatment guidelines for sinusitis 
contain different recommendations than the AAOHNS guideline (Chow et al., 2012; Rosenfeld 
et al., 2015). Yet, both of these guidelines are acceptable for use in clinical practice. This study 
sought to look at adherence to PQRS measures #331 and #332, which were written to reflect the 
AAOHNS guideline (American Medical Association, 2015). To summarize, if a patient 
encounter was not in alignment with PQRS measures #331 and #332, it does not necessarily 
demonstrate incorrect practice, which is how the results of this study could be interpreted.  
Finally, the last identified limitation of this study is that all nurse practitioners at the 
UKCONCHC are faculty members at the University of Kentucky College of Nursing in 
Lexington, Kentucky. As employees of an academic institution, there exists an expectation to 
maintain knowledge of current evidence-based practice. In an environment where evidence-
AN EVALUATION OF PROVIDER ADHERENCE 
 12 
based practice is encouraged, adherence rates to quality initiatives could be higher than they 
would be in private practice or rural communities where the motivation to stay abreast on current 
guidelines is not as high. This limitation does not affect the results of this study. However, it 
could impact how confidently this data could be extrapolated.   
Implications for Practice 
The results of this study reveal the current practice among providers at the UKCONCHC. 
Although the findings demonstrated practice was in alignment with PQRS measures and 
AAOHNS guideline most of the time, there remains room for improvement. A potential method 
to improve practice would be for nurse practitioners at the UKCONCHC to incorporate delayed 
prescription writing into practice. This practice would allow for a compromise between patients 
who believe they need an antibiotic for their illness and nurse practitioners who know evidence-
based guidelines state otherwise. The incorporation of delayed prescription writing into practice 
may help to improve adherence to PQRS measure #331 and #332.  
As previously mentioned in this paper, the results of this study will be used in a reflective 
manner by nurse practitioners at the UKCONCHC. However, another way to use this data would 
be to formulate an intervention designed to improve adherence to PQRS measures #331 and 
#332. If an intervention were to be designed in response to the results of this study, the focus of 
the intervention would be on Objective 1, waiting to prescribe an antibiotic until sinusitis 
symptoms have been experienced for at least 7 days.  This intervention would entail an education 
session regarding the quality measures and guideline included in this study, the results of this 
chart audit, and how the quality measures and guideline help to strengthen antibiotic 
stewardship. An emphasis would be placed on PQRS measure #331 during the education session. 
If desired, a repeat of this study could be conducted after this intervention to determine the 
interventions’ impact on practice.  
A potential resource for an intervention is the Get Smart About Antibiotics program, 
which is published by the CDC (2016b). This program provides printed materials regarding 
responsible antibiotic use for both patients and providers. Also, online resources are available for 
providers. The Get Smart About Antibiotics program could be used at the UKCONCHC to help 
improve patient understanding of responsible antibiotic use, which may have been an influencing 
factor in the results of this study as mentioned in the discussion section of this paper. In addition, 
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this program can provide tools for the nurse practitioners at the UKCONCHC to utilize in clinic 
that may improve adherence to PQRS measures #331 and #332.  
Conclusion 
In conclusion, the results of this retrospective chart audit demonstrate the need for 
improvement of adherence to PQRS measures #331 and #332. To improve adherence would not 
only affect the practice of medical providers at the UKCONCHC, but also promote the concept 
of antibiotic stewardship. Although this study examined three separate quality recommendations, 
it is imperative to realize that that they all work in combination to uphold antibiotic stewardship. 
Judicious practice of antibiotic stewardship is essential among all medical providers. The health 
of current and future populations depends on it. 
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Table 1: Demographic Information- Gender 
Gender Number of patient 
encounters 
Male 8 
Female 22 
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Table 2: Demographic Information- Age 
Age at date of encounter Number of patients in 
age group 
18-29 years of age 5 
30-39 years of age 14 
40-49 years of age 1 
50-59 years of age 8 
60-69 years of age 2 
70 years of age and older 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AN EVALUATION OF PROVIDER ADHERENCE 
 20 
Table 3: Results- Objective 1 
Symptoms present for at least seven 
days prior to antibiotic prescription 
Number of patient encounters 
Yes 18 
No 12 
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Table 4: Results- Objective 2 (Objective 1 adherence not considered) 
Amoxicillin or Amoxicillin/clavulanate 
prescribed 
Number of patient encounters 
Yes 25 
No 3 
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Table 5: Results- Objective 2 (Objective 1 adherence considered) 
Amoxicillin or amoxicillin/clavulanate 
prescribed after at least seven days of 
symptoms 
Number of patient encounters 
Yes 15 
No 13 
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Table 6: Results- Objective 3  
Fluroquinolone or doxycycline 
prescribed 
Number of patient encounters 
Yes 1 
No 1 
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
